Skip to main content
Clinical Trials/CTRI/2021/05/033301
CTRI/2021/05/033301
Recruiting
未知

Prospective, multi center, observational, study on evaluation of use of, â??AyurCoro3â?? as an adjuvant for the treatment purpose in mild to moderate COVID-19 patients at tertiary care center. - Ayurcoro-3 Extension

Shri Sarveshwar Seva Sahkari Samstha0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
Shri Sarveshwar Seva Sahkari Samstha
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Shri Sarveshwar Seva Sahkari Samstha

Eligibility Criteria

Inclusion Criteria

  • 1\.Laboratory confirmed diagnosis of Mild to Moderate COVID\-19 patients
  • 2\.Patients in whom Ayurcoro\-3 (as a adjuvant to the standard of care for mild to moderate covid\-19\) is prescribed by treating doctor.
  • 3\.All Age groups above 18 Years
  • 4\.All genders.

Exclusion Criteria

  • 1\.Patients on ventilator
  • 2\.Critically ill patient
  • 3\.Severe covid\-19 patients (Dyspnea, respiratory frequency \>\= 30/min, Blood oxygen saturation (SpO2\) \<\= 90%, PaO2/FiO2 ratio \< 300, and/or lung infiltrates \> 50% within 24 to 48 hours)
  • 4\.Patients not willing to consent for the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials